A new chemometrically optimised HPLC method for the simultaneous determination of imatinib mesylate and capecitabine, the active medicinal components-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A new chemometrically optimised HPLC method for the simultaneous determination of imatinib mesylate and capecitabine, the active medicinal components

Published:2024-07-17 Issue: Volume: Page:1-18
ISSN:0306-7319
Container-title:International Journal of Environmental Analytical Chemistry
language:en
Short-container-title:International Journal of Environmental Analytical Chemistry

Author:

Güray Tufan¹^ORCID,Alper Şirin²^ORCID,Uysal Ulku Dilek³^ORCID

Affiliation:

1. Faculty of Sciences, Department of Chemistry, Eskisehir Osmangazi University, Eskisehir, Turkey

2. Graduate School of Natural and Applied Sciences, Department of Chemistry, Eskisehir Osmangazi University, Eskisehir, Turkey

3. Department of Chemistry, Faculty of Science, Eskisehir Technical University, Eskisehir, Turkey

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03067319.2024.2378140

Reference51 articles.

1. Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome

2. Stochastic changes in gene expression promote chaotic dysregulation of homeostasis in clonal breast tumors

3. National Institute of Health (NIH) (National Cancer Institute February 2024). .

4. T. Sharma, Cancer and Regulation of Gene Expression, Understanding Cancer, from Basics to Therapeutics (Academic Press, Cambridge, Massachusetts, USA, 2022), pp. 205–216.

5. Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP